Danaher Appoints Martin Stumpe to New Role of CDAIO

Martin Stumpe, Danaher CDAIO
Martin Stumpe, Danaher CDAIO

(US and Canada) Danaher Corporation, a global science and technology innovator, announced the appointment of Dr. Martin Stumpe to the newly created role of Chief Data and Artificial Intelligence Officer (CDAIO).

Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer at Danaher, said: "We are delighted to welcome Dr. Stumpe to our team. His extensive experience in leveraging AI to drive scientific and operational progress will be critical in further supporting Danaher's AI and data strategy to advance innovation."

Dr. Stumpe most recently served as Chief of AI at Tempus, where he spearheaded AI initiatives aiming to make precision medicine a reality. Prior to Tempus, he founded the Cancer Pathology project at Google – which aimed to enhance the accuracy of cancer detection and grading using AI techniques – and was part of the Kepler team at NASA's Ames Research Center. Dr. Stumpe holds a Ph.D. in Computational & Theoretical Physics from the Max Planck Institute for Biophysical Chemistry in Germany. He will report to Dr. Gutierrez-Ramos.

Danaher is increasingly focusing on AI through inorganic investment, strengthening internal capabilities, and collaborating with leading academic institutions. In December, the company will host the third annual Danaher Summit, bringing together visionary leaders and innovators to discuss AI's potential impact on biopharmaceutical research and development.

Related Stories

No stories found.
CDO Magazine